NGM Biopharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. NGM Biopharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 92% to $4,417,000. The net income raised on -$142,375,000 and profit margin reached -3223%. Total operating expenses were $148,743,000.
Profit Margin
| 2016 | 85.58M | -6.92M | -8.09% |
|---|---|---|---|
| 2017 | 77.14M | -14.15M | -18.35% |
| 2018 | 108.66M | -493K | -0.45% |
| 2019 | 103.54M | -28.49M | -27.52% |
| 2020 | 87.36M | -93.99M | -107.58% |
| 2021 | 77.88M | -113.82M | -146.15% |
| 2022 | 55.33M | -159.08M | -287.5% |
| 2023 | 4.41M | -142.37M | -3223.34% |
NGM Income Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 4.41M | 55.33M | 77.88M | 87.36M | 103.54M | 108.66M | 77.14M | 85.58M |
Cost of revenue | 2.22M | 5.98M | 7.89M | 163.97M | 129.25M | 0 | 0 | 0 |
Gross profit | 2.19M | 49.34M | 69.98M | -76.60M | -25.70M | 108.66M | 77.14M | 85.58M |
Operating exp. | ||||||||
Research and development | 112.00M | 181.06M | 161.71M | 163.97M | 129.25M | 95.71M | 79.73M | 82.10M |
Selling and marketing | -1.10M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 148.74M | 221.58M | 198.57M | 191.20M | 152.88M | 112.97M | 94.56M | 93.95M |
Operating income | -146.54M | -166.24M | -120.69M | -103.83M | -49.34M | -4.31M | -17.42M | -8.36M |
Other income (expenses), net | 4.17M | 3.58M | 360K | 1.34M | 6.54M | 199K | 2.20M | 133K |
Income before tax | -142.37M | -162.66M | -120.33M | -102.48M | -42.79M | -493K | -15.21M | -6.42M |
Income tax expense | 0 | -3.58M | -6.50M | -8.49M | -14.29M | 3.82M | -1.06M | 500K |
Net income | -142.37M | -159.08M | -113.82M | -93.99M | -28.49M | -493K | -14.15M | -6.92M |
Earnings per share | ||||||||
Basic EPS | -1.73 | -1.99 | -1.48 | -1.37 | -0.57 | -0.00 | -0.26 | -0.13 |
Diluted EPS | -1.73 | -1.99 | -1.48 | -1.37 | -0.57 | -0.00 | -0.26 | -0.13 |
| Data source | Data source | Data source | Data source | Data source |